Studies of metabolic dysfunction-associated steatotic liver disease and viral hepatitis suggest a deleterious effect of STING signalling on hepatocytes [38] that could account for a possible increased risk of hepatoxicity in monogenic diseases driven by STING activation. The gene discussed is STING1; the disease is viral hepatitis.